계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Nurotron Biotechnology
company
About
Hangzhou Nurotron Biotechnology is a high-tech enterprise providing nerve electronic products.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $24M
- Industries
- Biotechnology,Electronics,Enterprise,Health Care
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Hangzhou Nurotron Biotechnology Co., Ltd., (诺尔康神经电子科技) is a high-tech enterprise providing nerve electronic products. The company is mainly involved in the R&D of multipath manual electrical cochlea systems, nationalization and clinical application of auditory brainstem implant equipment, strategy and technology enhancement of home-grown manual cochlea, and more. The company’s headquarters and production base are located in Hangzhou, China, and its R&D center is located in California, USA.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$24M
Nurotron Biotechnology has raised a total of
$24M
in funding over 2 rounds. Their latest funding was raised on
Oct 9, 2020 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 9, 2020 | Series E | $24M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Nurotron Biotechnology is funded by 1 investors.
Superstring Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
